Company intelligence / Profile preview
ImmunoRestoration
Warminster/Doylestown*, Pennsylvania, United Statesimmunorestoration.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Other
01
Overview
ImmunoRestoration’s dendritic cell-based vaccines have shown promising efficacy in early clinical trials for breast cancer, with higher efficacy than some existing treatments based on Phase I and II data. The company is expanding into multi-center trials focused on DCIS and continues to develop additional indications. Ir-Vax is currently in Phase I for HER2-negative breast cancer. A Phase II trial combining their DC1 vaccine with paclitaxel, trastuzumab, and pertuzumab is ongoing in patients with HER2-positive disease.
- Therapeutic areas
- Oncology
- Modalities
- Dendritic cell vaccineTherapeutic vaccineCell therapy
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
University of PennsylvaniaMoffitt Cancer CenterPennies in ActionThe Werner and Mary Henle Foundation
Beyond the preview
Go deeper on ImmunoRestoration.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmunoRestoration.